Veru (NASDAQ:VERU – Get Free Report) and Nascent Biotech (OTCMKTS:NBIO – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, institutional ownership, profitability, earnings and risk. Analyst Recommendations This is a breakdown of recent ratings […]
Veru (NASDAQ:VERU – Get Free Report) and U.S. Stem Cell (OTCMKTS:USRM – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Analyst Ratings This is a breakdown of […]
Jefferies Financial Group upgraded shares of Veru (NASDAQ:VERU – Get Rating) from an underperform rating to a hold rating in a report published on Wednesday morning, MarketBeat Ratings reports. VERU has been the topic of several other research reports. Oppenheimer reduced their target price on shares of Veru from $14.00 to $9.00 and set an […]
Jefferies Financial Group upgraded shares of Veru (NASDAQ:VERU – Get Rating) from an underperform rating to a hold rating in a research note released on Wednesday, Marketbeat Ratings reports. Other equities research analysts also recently issued reports about the stock. HC Wainwright dropped their price objective on shares of Veru from $6.00 to $2.00 in […]
Global Future City (OTCMKTS:FTCY – Get Rating) and Veru (NASDAQ:VERU – Get Rating) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings and risk. Risk & Volatility Global Future City has a beta […]